Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prediction of Adalimumab Treatment Response at 6 Months by Combinatorial Analysis of Serum Biomarkers in Biotherapy Naive Spondyloarthritis: Pilot Study

NCT03561649 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT03561649
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03561649 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prediction of Adalimumab Treatment Response at 6 Months by Combinatorial Analysis of Serum Biomarkers in Biotherapy Naive Spondyloarthritis: Pilot Study
Lead sponsor
University Hospital, Grenoble
Phase
Not applicable
Overall status
Completed
Start date
June 14, 2018
Completion date
May 7, 2020
Enrollment
50 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

spondylitis, ankylosing